Manokast 10mg Tablet

Introduction

Manokast is a prescription medication that contains the active ingredient Montelukast. It is available in tablet form and is commonly prescribed for the management of certain respiratory conditions.

Uses

Manokast is primarily used for the treatment of asthma and allergic rhinitis. It helps to control symptoms such as wheezing, shortness of breath, coughing, and nasal congestion associated with these conditions.

Dosage and Administration

The dosage of Manokast will vary depending on the individual’s age, medical condition, and response to treatment. Follow the instructions provided by your healthcare professional. Generally, the recommended dosage for adults and children over 15 years of age is one tablet taken orally once daily, with or without food.

Mechanism of Action

Montelukast, the active ingredient in Manokast, works by blocking the action of certain chemicals in the body that cause inflammation in the airways. By reducing inflammation, it helps to prevent asthma attacks and relieve symptoms of allergic rhinitis.

Side Effects

Common side effects may include headache, dizziness, nausea, diarrhea, and fatigue. These side effects are usually mild and temporary. However, if you experience any persistent or severe side effects, seek medical attention.

In rare cases, Manokast may cause serious side effects such as mood or behavior changes, suicidal thoughts, allergic reactions, or liver problems. If you experience any of these serious side effects, stop taking the medication and seek immediate medical attention.

Drug Interactions

Manokast may interact with certain medications, including phenobarbital, rifampin, and phenytoin. Inform your healthcare professional about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements, to avoid any potential drug interactions.

Precautions

Before taking Manokast, inform your healthcare professional if you have any allergies, liver disease, or a history of mental health problems. Additionally, disclose all medications you are currently taking to ensure the safe use of this medication.

Manokast is not recommended for use in children under 15 years of age. It is also contraindicated in individuals with a known hypersensitivity to Montelukast or any other component of the tablet.

Storage

Manokast should be stored at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Do not use the medication after the expiration date printed on the packaging.

Patient Tips

• Follow the dosage instructions provided by your healthcare professional.
• Take Manokast at the same time each day to help you remember.
• If you forget to take a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Do not stop taking Manokast without consulting your healthcare professional, as abruptly stopping the medication may worsen your symptoms.
• If you have any concerns or questions about your treatment with Manokast, speak to your healthcare professional for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Montelukast: a medicine to prevent asthma symptoms (NHS UK) [Accessed 10 Jun. 2024] (online) Available at:
• Montelukast 10 mg film-coated tablets (Health Professionals SmPC) Available at:
• Montelukast (Drugs.com) [Accessed 20 Jun. 2024] (online) Available at:
• montelukast (singulair) (RX) [Accessed 25 Jun. 2024] (online) Available at:
• Montelukast (MedlinePlus) [Accessed 22 Jun. 2024] (online) Available at:
• Paljarvi T, Forton J, Luciano S, Herttua K, Fazel S. Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation. JAMA Netw Open. 2022 May 2;5(5):e2213643. doi: 10.1001/jamanetworkopen.2022.13643. [Accessed 22 Jun. 2024] Available at: